pubmed-article:10228057 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0003451 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0030946 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C1442488 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:10228057 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:10228057 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:10228057 | pubmed:dateCreated | 1999-6-21 | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:abstractText | Twenty human immunodeficiency virus-infected patients experiencing virologic failure of an indinavir- or ritonavir-containing treatment regimen were evaluated in a prospective, open-label study. Subjects received nelfinavir, saquinavir, abacavir, and either another nucleoside analog (n=10) or nevirapine (n=10). Patients treated with the nevirapine-containing regimen experienced significantly greater virologic suppression at week 24 than those not treated with nevirapine (P=.04). Baseline phenotypic drug susceptibility was strongly correlated with outcome in both treatment arms. Subjects with baseline virus phenotypically sensitive to 2 or 3 drugs in the salvage regimen experienced significantly greater virus load suppression than those with baseline virus sensitive to 0 or 1 drug (median week-24 change=-2.24 log and -0.35 log, respectively; P=.01). In conclusion, non-nucleoside reverse transcriptase inhibitors may represent a potent drug in salvage therapy regimens after failure of an indinavir or ritonavir regimen. Phenotypic resistance testing may provide a useful tool for selecting more effective salvage regimens. | lld:pubmed |
pubmed-article:10228057 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:language | eng | lld:pubmed |
pubmed-article:10228057 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10228057 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10228057 | pubmed:month | Jun | lld:pubmed |
pubmed-article:10228057 | pubmed:issn | 0022-1899 | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:BeckerMM | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:VolberdingP... | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:GrantR MRM | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:ParkinN TNT | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:ChesneyMM | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:PetropoulosC... | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:HellmannN SNS | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:DeeksS GSG | lld:pubmed |
pubmed-article:10228057 | pubmed:author | pubmed-author:SymondsWW | lld:pubmed |
pubmed-article:10228057 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10228057 | pubmed:volume | 179 | lld:pubmed |
pubmed-article:10228057 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10228057 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10228057 | pubmed:pagination | 1375-81 | lld:pubmed |
pubmed-article:10228057 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:meshHeading | pubmed-meshheading:10228057... | lld:pubmed |
pubmed-article:10228057 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10228057 | pubmed:articleTitle | Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. | lld:pubmed |
pubmed-article:10228057 | pubmed:affiliation | University of California, San Francisco, AIDS Program. San Francisco General Hospital, San Francisco General Hospital, San Francisco, CA 94110, USA. sdeeks@sfaids.ucsf.edu | lld:pubmed |
pubmed-article:10228057 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10228057 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10228057 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:10228057 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
pubmed-article:10228057 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10228057 | lld:pubmed |